However, along with HCC, there are other tumor contributors to the rise of AFP levels, such as reproductive system tumors; besides, the process of liver cell regeneration after an acute inflammation could also lead to the occurrence of a sharp increase in AFP levels during the progress of chronic liver diseases like hepatitis and liver cirrhosis[89–91]. This evidence concerns the gene AFP and hepatocellular carcinoma.